NCT00776516View on ClinicalTrials.gov

Pharmacokinetic Interaction Study to Assess the Effect of Repeat Doses of Rifampin on Mirabegron (YM178) in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Pharmacokinetics of YM178
Interventions
DRUG

mirabegron

oral

DRUG

rifampin

oral

Trial Locations (1)

33126

Miami

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00776516 - Pharmacokinetic Interaction Study to Assess the Effect of Repeat Doses of Rifampin on Mirabegron (YM178) in Healthy Volunteers | Biotech Hunter | Biotech Hunter